16603583

Source:http://linkedlifedata.com/resource/pubmed/id/16603583

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0019189, umls-concept:C0036043, umls-concept:C0205420, umls-concept:C0281481, umls-concept:C0949691
pubmed:issue	10
pubmed:dateCreated	2006-9-25
pubmed:abstractText	To assess the safety of anti-tumour necrosis factor (TNF)-alpha therapy in patients with rheumatoid arthritis (RA) or spondylarthropathies (SA) and concurrent chronic hepatitis B or C.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16603583-17245347, http://linkedlifedata.com/resource/pubmed/commentcorrection/16603583-17567635
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883501
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein, http://linkedlifedata.com/resource/pubmed/chemical/Transaminases, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/adalimumab, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1462-0324
pubmed:author	pubmed-author:AlbertCC, pubmed-author:BreuilVV, pubmed-author:BrocqOO, pubmed-author:Euller-ZieglerLL, pubmed-author:RouxC HCH
pubmed:issnType	Print
pubmed:volume	45
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1294-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16603583-Antibodies, Monoclonal, pubmed-meshheading:16603583-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16603583-Antirheumatic Agents, pubmed-meshheading:16603583-Antiviral Agents, pubmed-meshheading:16603583-Arthritis, Rheumatoid, pubmed-meshheading:16603583-Drug Therapy, Combination, pubmed-meshheading:16603583-Female, pubmed-meshheading:16603583-Hepatitis, Chronic, pubmed-meshheading:16603583-Hepatitis B, Chronic, pubmed-meshheading:16603583-Hepatitis C, Chronic, pubmed-meshheading:16603583-Humans, pubmed-meshheading:16603583-Immunoglobulin G, pubmed-meshheading:16603583-Lamivudine, pubmed-meshheading:16603583-Male, pubmed-meshheading:16603583-Middle Aged, pubmed-meshheading:16603583-Receptors, Tumor Necrosis Factor, pubmed-meshheading:16603583-Retrospective Studies, pubmed-meshheading:16603583-Spondylarthropathies, pubmed-meshheading:16603583-Transaminases, pubmed-meshheading:16603583-Treatment Outcome, pubmed-meshheading:16603583-Tumor Necrosis Factor-alpha, pubmed-meshheading:16603583-Viral Load
pubmed:year	2006
pubmed:articleTitle	Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis.
pubmed:affiliation	Hospital l'Archet 1, Rheumatology Department, 242 Avenue de Saint Antoine de Ginestiere, 06200 Nice, France. roux101fr@yahoo.fr
pubmed:publicationType	Journal Article, Case Reports